Personal Injury: Study Confirms Ortho Evra Risks

On 20 September, Ortho-McNeil and the FDA informed doctors and patients of a study which found that Ortho Evra users were twice as likely to be victims of venous thromboembolism (VTE) events then users of typical oral birth control. This study supports the claim that Ortho Evra substantially increases the risk of blood clots in women.

The Ortho Evra label has also been updated to notify women regarding the elevated risk of blood clots while using this product. The Ortho Evra patch is used as a form of contraceptive, and when placed on the skin releases estrogen and progestin directly into the bloodstream. This process causes estrogen to be absorbed into the body at much higher levels then the pill.